Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

Phase III Tolerance and Efficacy Study of RSD1235 in Patients With Atrial Fibrillation

ClinicalTrials.gov ID: NCT00468767

Public ClinicalTrials.gov record NCT00468767. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 6, 2026, 6:55 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase III Prospective, Randomized, Double-Blind, Placebo-Controlled, Multi-Centred Tolerance and Efficacy Study of RSD1235 in Patients With Atrial Fibrillation

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study is being conducted to demonstrate the effectiveness of RSD1235 in the conversion of atrial fibrillation to sinus rhythm.

Study identification

NCT ID
NCT00468767
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Advanz Pharma
Industry
Enrollment
356 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 31, 2003
Primary completion
Oct 31, 2004
Completion
Oct 31, 2004
Last update posted
Apr 1, 2008

2003 – 2004

United States locations

U.S. sites
11
U.S. states
8
U.S. cities
10
Facility City State ZIP Site status
University of California Los Angeles California 90073
Regional Cardiology Associates Sacramento California 95819
Florida Heart Institute Orlando Florida 32803
James Haley VA Hospital Tampa Florida 33612
Cardiac Arrhythmia Service, Massachusetts General Hospital Boston Massachusetts 02459
Thoracic and Cardiovascular Institute Lansing Michigan 48910
Oregon Health & Science University Portland Oregon 97201
Main Line Health Heart Center Wynnewood Pennsylvania 19096
Medical College of Virginia Richmond Virginia 23219
McGuire VA Medical Center Richmond Virginia 23249
Marshfield Clinic Marshfield Wisconsin 54449

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 38 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00468767, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 1, 2008 · Synced Sep 6, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00468767 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →